fig1

Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon

Figure 1. The mutated genes and potential targets in cholangiocarcinoma.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/